Compare KFRC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KFRC | CTKB |
|---|---|---|
| Founded | 1962 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.7M | 652.1M |
| IPO Year | 1996 | 2021 |
| Metric | KFRC | CTKB |
|---|---|---|
| Price | $26.20 | $4.01 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $38.50 | $5.70 |
| AVG Volume (30 Days) | 278.4K | ★ 687.9K |
| Earning Date | 05-04-2026 | 05-20-2026 |
| Dividend Yield | ★ 6.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | ★ $1,329,007,000.00 | $193,015,000.00 |
| Revenue This Year | $2.78 | $5.02 |
| Revenue Next Year | $4.32 | $7.89 |
| P/E Ratio | $13.12 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $24.49 | $2.37 |
| 52 Week High | $51.13 | $6.18 |
| Indicator | KFRC | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 30.90 |
| Support Level | $24.87 | $3.81 |
| Resistance Level | $28.41 | $4.26 |
| Average True Range (ATR) | 1.22 | 0.21 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 32.19 | 9.23 |
Kforce Inc is a solutions firm specializing in technology, finance, accounting, and other professional staffing services. The company operates two business segments: the Technology segment, which provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. The FA segment offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting, business and cost analysis; and taxation and treasury. The majority of revenue is earned through the Technology segment.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.